Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Khyati Shah, PhD

    Address1450 3rd Street
    San Francisco CA 94158
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Shah KN, Wilson EA, Malla R, Elford HL, Faridi JS. Targeting Ribonucleotide Reductase M2 and NF-?B Activation with Didox to Circumvent Tamoxifen Resistance in Breast Cancer. Mol Cancer Ther. 2015 Nov; 14(11):2411-21. PMID: 26333382.
        View in: PubMed
      2. Shah KN, Mehta KR, Peterson D, Evangelista M, Livesey JC, Faridi JS. AKT-induced tamoxifen resistance is overturned by RRM2 inhibition. Mol Cancer Res. 2014 Mar; 12(3):394-407. PMID: 24362250.
        View in: PubMed
      3. KN Shah, JS Faridi. . Voyagers and their aids: The role of interactions between tumor and endothelial cells in brain metastasis. 2012.
      4. Shah KN, Faridi JS. Estrogen, tamoxifen, and Akt modulate expression of putative housekeeping genes in breast cancer cells. J Steroid Biochem Mol Biol. 2011 Jul; 125(3-5):219-25. PMID: 21420492.
        View in: PubMed
      5. Khyati Niral Shah and Jesika S. Faridi. . Estrogen, tamoxifen, and Akt modulate expression of putative housekeeping genes in breast cancer cells.
      6. Khyati Niral Shah, David Peterson, Marie Evangelista, and Jesika Faridi. . RRM2: a key contributor in tamoxifen resistance in breast cancer.
      7. Khyati N. Shah, Howard L. Elford, and Jesika S. Faridi. . The ribonucleotide reductase inhibitor Didox reverses tamoxifen resistance in breast cancer cells.
      8. Shah KN, Faridi JS. . Identification of altered genes in tamoxifen resistant breast cancer.
      9. Shah KN, Peterson D, Kowanetz K, and Evangelista M. . Mapping out the "altered" metabolic network in pancreatic cancer by integration of methylation profiling and RNA-seq Genentech Inc.
      10. Shah KN, and Evangelista, M . . Mutations in IDH1 enhances sensitivity to LDHA inhibitors, Genentech.
      Khyati's Networks
      Related Concepts
      Derived automatically from this person's publications.
      Related Authors
      People who share related concepts with this person.
      Back to TOP